Morphotek blueprints $80M manufacturing facility

Morphotek has acquired three buildings in Exton, PA with plans to raze them and build an $80 million manufacturing facility that will make experimental drugs for clinical trials. "Ultimately, our goal is to be a fully integrated biopharmaceutical company and having your own manufacturing facility is part of that process," says CEO Nicholas Nicolaides. Report

Suggested Articles

Half of patients in an early trial of Allogene's off-the-shelf CAR-T cells for lymphoma who received a higher dose of its antibody ALLO-647 responded.

Takeda is tossing out a Shire pipeline med after it couldn't find a buyer.

Ipsen's new hire arrives at a company reeling from a torrent six months that have crushed hopes for its $1 billion bet on a rare disease drug.